The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.
In this interview from the AACR Annual Meeting 2026, Shuguang Leng, MBBS, PhD, an associate professor at the University of New Mexico Comprehensive Cancer Center,
Selinexor was originally granted accelerated approval for this indication on June 22, 2020. The withdrawal does not affect the other approved indications for selinexor in multiple myeloma.
Meet Naval Daver, MD, a professor and director of the Leukemia Molecular Laboratory in the Department of Leukemia at the University of Texas MD Anderson Cancer Center.
In this SOHO Insider interview from the 2026 AACR Annual Meeting, Roy Jensen, MD, vice chancellor and director of the University of Kansas Cancer Center (KU Cancer Center), discusses point-of-care CAR-T manufacturing and the regulatory challenges associated with the process.
In this SOHO Insider podcast, host Megan Melody, MD, from Tampa General Hospital, spoke with Nirav Shah, MD, professor at the Medical College of Wisconsin,
To access the SOHO Career Center click the following link.
